NanoX Pain Relieving

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
NanoX Pain Relieving
Generic name
MENTHOL, METHYL SALICYLATE
Manufacturer
MG Science Technologies LLC
Product type
HUMAN OTC DRUG
SPL set ID
4cc38927-8a8c-2df3-e063-6294a90aa0c1
SPL ID
4cc38936-69fa-299f-e063-6294a90a9e69
Version
1
Effective date
2026-03-12
Source export date
2026-09-28
Source partition
1
Source file
https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:12:33
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Wash hands thoroughly before and after each use and cap bottle tightly. Flammable - Keep away from fire or flame. Avoid contact with the eyes. Do not apply to wounds or damaged skin. Do not bandage tightly. Do not use on reddened, damaged or sensitive skin. If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor Ask a doctor before use if: You are pregnant, breast feeding, have sensitive skin, are allergic to any ingredients, or are taking any prescription medications. Keep out of reach of children. If swallowed, get medical help or contact the Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.